Novacyt
Presence
Novacyt is a company listed under the stock ticker NCYT (GB).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at Novacyt
- James McCarthy, Acting Chief Executive Officer, Chief Financial Of...
- Juliet Thompson, Non-Executive Director
- Jean-Pierre Crinelli, Non-Executive Director
Popular executive movements at Novacyt
- Steve Gibson, who was Group Finance Director, is promoted to Chief Financial Officer (posted on January 3 2024).
Create your alert
to follow the executive moves at Novacyt.
Biotechnology
Novacyt has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
- Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Novacyt
- News and Events - Page 43 of 43 - Novacyt
- News and Events - Page 42 of 42 - Novacyt
- News and Events - Page 41 of 41 - Novacyt
- News and Events - Page 40 of 40 - Novacyt
- News and Events - Page 39 of 39 - Novacyt
- News Archives - Novacyt
- News and Events - Page 88 of 88 - Novacyt
- News and Events - Page 87 of 87 - Novacyt
- News and Events - Page 82 of 82 - Novacyt
- News and Events - Page 81 of 81 - Novacyt
- View more press releases Close
Social media about Novacyt
- Novacyt on Wikipedia, Google News & Yahoo Finance
- Novacyt on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including James McCarthy 
